Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

BMGL US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Basel Medical Group Ltd(BMGL US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

BMGL US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Basel Medical Group Ltd(BMGL US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials & Metrics

FinancialsChartingShort InterestEmployees

Basel Medical Group Ltd — Company Profile

Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including specialist medical expertise, medical supplies and equipment, advanced medical technology solutions, and pharmaceutical products.

Sector
Consumer Staples
Industry
Personal Care Products
Exchange
UQ
CEO
Yen Feng Chhoa
Headquarters
Singapore, U0, SG
IPO Date
Feb 25, 2025
Employees
82
Website
baselmedical.com

Key Metrics

Price
$3.28
Market Cap
$5.13M
Revenue (TTM)
$11.32M
Net Income (TTM)
$-12087603.00
EPS (TTM)
0.00
P/E (TTM)
0.00
P/B (TTM)
1.06
Dividend Yield
0.00%
ROE (TTM)
-248.66%
ROA (TTM)
-71.72%
Operating Margin
-19.28%
Beta
-2.45

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including specialist medical expertise, medical supplies and equipment, advanced medical technology solutions, and pharmaceutical products.

Website
baselmedical.com
Location
Singapore, U0, SG
Phone65 6291 9188
Employees82
CEOYen Feng Chhoa
Sector
Consumer Staples
Industry
Personal Care Products
IPO DateFeb 25, 2025

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(79)

Expand
  • 20-FFY 2026ended 30 Jun 202630 Oct
  • 6-KCurrent report (foreign private issuer)29 Oct
  • Form 3Yang Xinwen21 Oct
  • 6-KCurrent report (foreign private issuer)13 Oct
  • 6-KCurrent report (foreign private issuer)9 Oct
  • 424B4Prospectus filing (Rule 424(b)(4))8 Oct
  • Form 3Hong Frederick Shieh Ming1 Oct
  • EFFECTNotice of effectiveness30 Sep
  • F-1/ARegistration statement (foreign issuer, amendment)23 Sep
  • F-1Registration statement (foreign issuer)17 Sep
  • 6-KCurrent report (foreign private issuer)2 Sep
  • 6-KCurrent report (foreign private issuer)10 Aug
  • DRSDraft registration statement31 Jul
  • Form 3Neo Alton Chun How22 Jul
  • 6-KCurrent report (foreign private issuer)10 Jul
  • 6-KCurrent report (foreign private issuer)26 Jun
  • 6-KCurrent report (foreign private issuer)10 Jun
  • 6-KCurrent report (foreign private issuer)5 Jun
  • Form 3Soong Kwek Yoon21 Apr
  • Form 3Lu Jianing JN15 Apr

News

  • Basel Medical Group Ltd (BMGL) Closes Registered Direct Offering9 Oct
  • Basel Medical Group Ltd (BMGL) Prices Registered Direct Offering8 Oct

Key Stats

Trading

Px/Chg 1D$3.28 / +8.61%
Prev Close$4.78
% of 52Wk H45.09%
Avg Volume409.24K
Beta-2.45
Mkt Cap5.13M
FD Mkt Cap7.48M

Float

Shrs Out/Float1.57M / 435.95K
Short Float0.03%
Days to Cover1.01
Stock Repurchased$0.00

Current Valuation

EV5.58M
EV/EBITDA0.00
EV/Sales0.00
P/B1.06
P/S0.00
FCF Yield-85.67%
ROE-248.66%
ROA-71.72%
Current Ratio1.23

Estimates

P/E0.00
Est P/E0.00
Est EPS0.00
Est PEG0.00

Valuation

Metric5Yr AvgNov '25Oct '26
PRICE-BASED RATIOS
Price / Earnings4.8310.13-0.47
Price / Sales1.292.090.50
Price / Book Value2.032.891.16
Price / Free Cash Flow3.568.40-1.28
ENTERPRISE VALUE METRICS
Enterprise Value12.017.96.1
Enterprise Value / Sales1.161.780.54
Enterprise Value / EBITDA2.615.76-0.55
Enterprise Value / EBIT3.236.95-0.49

Financials

Full Financials
Millions SGD5Yr CAGR (%)Jun '22Jun '23Jun '24Jun '25Jun '26
INCOME STATEMENT
Revenue19.2%10.79.710.111.321.5
Gross Income-41.4%8.57.47.88.88.3
EBITDA—3.32.93.1-11.1-0.4
EBIT—2.72.42.6-12.3-0.8
Net Income—2.01.82.1-12.1-0.7
EPS (Diluted)—0.110.100.110.00-0.78
BALANCE SHEET
Cash & ST Inv-23.7%1.61.22.03.00.5
Total Assets1.4%16.815.416.316.917.8
Total Liabilities20.7%13.19.98.712.013.3
Total Shareholder Equity8.1%3.75.57.64.95.1
CASH FLOW
Net Operating Cash Flow—2.82.62.5-4.3-0.6
Cap Ex29.4%-0.1-0.0-0.0-0.1-0.2
Free Cash Flow—2.72.62.5-4.4-0.9

Enterprise Value Bridge

Millions SGD13 Nov '26
Price (As of 13 Nov '26)0.47
Basic Shares1.57
Market Cap0.7
Diluted Shares1.58
Fully Diluted Shares Outstanding1.58
Fully Diluted Market Cap0.7
+Consolidated Debt9.6
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-0.5
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-0.5
+Pension Liabilities—
Enterprise Value9.3

Segment data

Revenue

by Products and services

  • Medical Services100%

Related companies

HCA Healthcare, Inc.

HCA US

Tenet Healthcare Corp

THC US

Universal Health Services Inc

UHS US

Hims & Hers Health, Inc.

HIMS US

Surgery Partners, Inc.

SGRY US

Teladoc Health, Inc.

TDOC US

Community Health Systems Inc

CYH US

Auna S.a.

AUNA US

PHYHEALTH Corp

OSCI US

Rennova Health, Inc.

RNVA US

Cardiff Lexington Corp

CDIX US

Basel Medical Group Ltd — Company Profile

Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including specialist medical expertise, medical supplies and equipment, advanced medical technology solutions, and pharmaceutical products.

Sector
Consumer Staples
Industry
Personal Care Products
Exchange
UQ
CEO
Yen Feng Chhoa
Headquarters
Singapore, U0, SG
IPO Date
Feb 25, 2025
Employees
82
Website
baselmedical.com

Key Metrics

Price
$3.28
Market Cap
$5.13M
Revenue (TTM)
$11.32M
Net Income (TTM)
$-12087603.00
EPS (TTM)
0.00
P/E (TTM)
0.00
P/B (TTM)
1.06
Dividend Yield
0.00%
ROE (TTM)
-248.66%
ROA (TTM)
-71.72%
Operating Margin
-19.28%
Beta
-2.45

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including specialist medical expertise, medical supplies and equipment, advanced medical technology solutions, and pharmaceutical products.

Website
baselmedical.com
Location
Singapore, U0, SG
Phone65 6291 9188
Employees82
CEOYen Feng Chhoa
Sector
Consumer Staples
Industry
Personal Care Products
IPO DateFeb 25, 2025

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(79)

Expand
  • 20-FFY 2026ended 30 Jun 202630 Oct
  • 6-KCurrent report (foreign private issuer)29 Oct
  • Form 3Yang Xinwen21 Oct
  • 6-KCurrent report (foreign private issuer)13 Oct
  • 6-KCurrent report (foreign private issuer)9 Oct
  • 424B4Prospectus filing (Rule 424(b)(4))8 Oct
  • Form 3Hong Frederick Shieh Ming1 Oct
  • EFFECTNotice of effectiveness30 Sep
  • F-1/ARegistration statement (foreign issuer, amendment)23 Sep
  • F-1Registration statement (foreign issuer)17 Sep
  • 6-KCurrent report (foreign private issuer)2 Sep
  • 6-KCurrent report (foreign private issuer)10 Aug
  • DRSDraft registration statement31 Jul
  • Form 3Neo Alton Chun How22 Jul
  • 6-KCurrent report (foreign private issuer)10 Jul
  • 6-KCurrent report (foreign private issuer)26 Jun
  • 6-KCurrent report (foreign private issuer)10 Jun
  • 6-KCurrent report (foreign private issuer)5 Jun
  • Form 3Soong Kwek Yoon21 Apr
  • Form 3Lu Jianing JN15 Apr

News

  • Basel Medical Group Ltd (BMGL) Closes Registered Direct Offering9 Oct
  • Basel Medical Group Ltd (BMGL) Prices Registered Direct Offering8 Oct

Key Stats

Trading

Px/Chg 1D$3.28 / +8.61%
Prev Close$4.78
% of 52Wk H45.09%
Avg Volume409.24K
Beta-2.45
Mkt Cap5.13M
FD Mkt Cap7.48M

Float

Shrs Out/Float1.57M / 435.95K
Short Float0.03%
Days to Cover1.01
Stock Repurchased$0.00

Current Valuation

EV5.58M
EV/EBITDA0.00
EV/Sales0.00
P/B1.06
P/S0.00
FCF Yield-85.67%
ROE-248.66%
ROA-71.72%
Current Ratio1.23

Estimates

P/E0.00
Est P/E0.00
Est EPS0.00
Est PEG0.00

Valuation

Metric5Yr AvgNov '25Oct '26
PRICE-BASED RATIOS
Price / Earnings4.8310.13-0.47
Price / Sales1.292.090.50
Price / Book Value2.032.891.16
Price / Free Cash Flow3.568.40-1.28
ENTERPRISE VALUE METRICS
Enterprise Value12.017.96.1
Enterprise Value / Sales1.161.780.54
Enterprise Value / EBITDA2.615.76-0.55
Enterprise Value / EBIT3.236.95-0.49

Financials

Full Financials
Millions SGD5Yr CAGR (%)Jun '22Jun '23Jun '24Jun '25Jun '26
INCOME STATEMENT
Revenue19.2%10.79.710.111.321.5
Gross Income-41.4%8.57.47.88.88.3
EBITDA—3.32.93.1-11.1-0.4
EBIT—2.72.42.6-12.3-0.8
Net Income—2.01.82.1-12.1-0.7
EPS (Diluted)—0.110.100.110.00-0.78
BALANCE SHEET
Cash & ST Inv-23.7%1.61.22.03.00.5
Total Assets1.4%16.815.416.316.917.8
Total Liabilities20.7%13.19.98.712.013.3
Total Shareholder Equity8.1%3.75.57.64.95.1
CASH FLOW
Net Operating Cash Flow—2.82.62.5-4.3-0.6
Cap Ex29.4%-0.1-0.0-0.0-0.1-0.2
Free Cash Flow—2.72.62.5-4.4-0.9

Enterprise Value Bridge

Millions SGD13 Nov '26
Price (As of 13 Nov '26)0.47
Basic Shares1.57
Market Cap0.7
Diluted Shares1.58
Fully Diluted Shares Outstanding1.58
Fully Diluted Market Cap0.7
+Consolidated Debt9.6
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-0.5
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-0.5
+Pension Liabilities—
Enterprise Value9.3

Segment data

Revenue

by Products and services

  • Medical Services100%

Related companies

HCA Healthcare, Inc.

HCA US

Tenet Healthcare Corp

THC US

Universal Health Services Inc

UHS US

Hims & Hers Health, Inc.

HIMS US

Surgery Partners, Inc.

SGRY US

Teladoc Health, Inc.

TDOC US

Community Health Systems Inc

CYH US

Auna S.a.

AUNA US

PHYHEALTH Corp

OSCI US

Rennova Health, Inc.

RNVA US

Cardiff Lexington Corp

CDIX US